Basem M Mishriky
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 16, 2024
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world data.Basem M Mishriky, Doyle M Cummings, Yuanyuan Fu
|Oct 01, 2020
Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials.Victor Okunrintemi, Basem M Mishriky, James R Powell
|May 13, 2020
Should Baseline Hemoglobin A1c or Dose of SGLT-2i Guide Treatment With SGLT-2i Versus DPP-4i in People With Type 2 Diabetes? A Meta-Analysis and Systematic Review.Jarrod L Uhrig, Stephanie O Page, Basem M Mishriky
|Jul 18, 2019
Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality.Carlos E Mendez, Rebekah J Walker, Christian R Eiler
|Jun 07, 2019
Do GLP-1RAs and SGLT-2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta-analysis.Basem M Mishriky, James R Powell, Jennifer A Wittwer
|Oct 11, 2018
Re-examining insulin compared to non-insulin therapies for type 2 diabetes: when in the disease trajectory is insulin preferable?Basem M Mishriky, Doyle M Cummings, Robert Tanenberg
Pageof 2
